News Focus
News Focus
Followers 84
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: golfho post# 244591

Sunday, 12/06/2015 12:31:39 AM

Sunday, December 06, 2015 12:31:39 AM

Post# of 347009

Please place beneath my Christmas tree the following.

12-10-15 PPHM C.C…Today PPHM announces that it’s wholly owned subsidiary AVID Bioservices has firm new contracts for it’s new AVID II facilities of over $50M and are now projecting revenue for fiscal year 2016 to exceed $45M…Or something like that.

Before 12-31-15 PPHM announces that its pivotal clinical trial SUNRISE has now completed enrollment and we look forward to updating you as the data matures…Along with some suitable words of enthusiasm and encouragement.

Before 12-31-15 PPHM announces the initiation of a new Phase II/III trial to evaluate bavituximab with chemotherapy combinations in HER2-negative metastatic breast cancer.

I thank you in advance for your consideration. And please remember…this request is not only for me but for the many cancer patients and families that are now suffering and of course…for the many loyal shareholders…Some of whom appear to be rapidly losing it.

Yours truly and humbly
golfho
..
..



thanks for the post golfho and that is one wish that pays back every single one of us at some point in our lives, maybe even causing that 7 day fight with a cold down to a couple days with the proper PS Targeting active ingredients, vs 25% alcohol : )

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y